AAM
NUVB icon

AMI Asset Management’s Nuvation Bio NUVB Stock Holding History

AMI Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$826K Buy
192,427
+65,955
+52% +$367K 0.05% 64
2025
Q4 		$1.13M Buy
+126,472
New +$783K 0.06% 55

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AMI Asset Management's NUVB Position: Q1 2026 in Review

AMI Asset Management increased its Nuvation Bio (NUVB) stake by 52% in Q1 2026, buying an estimated $367K and bringing the position to 192,427 shares worth $826K. The position accounts for 0.05% of the portfolio, ranked #64.

AMI Asset Management first reported a position in NUVB in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.13M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • AMI Asset Management held 192,427 shares of Nuvation Bio worth $826K as of Q1 2026.
  • AMI Asset Management bought 65,955 Nuvation Bio shares in Q1 2026, an estimated $367K.
  • Nuvation Bio made up 0.05% of AMI Asset Management's portfolio in Q1 2026, its #64 holding.
  • AMI Asset Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 2 quarters since.
  • AMI Asset Management's Nuvation Bio position peaked at $1.13M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on AMI Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.